Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Radiation Injuries × Lisinopril × 90 days × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Radiation Injuries 1 Prostatic Neoplasms 1 Non-alcoholic Fatty Liver Disease 1 Carcinoma, Hepatocellular 1

Interventions

Radiotherapy 3 Xylitol 1 Radiography, Panoramic 1 Oral Hygiene 1 Lymph Node Excision 1 Lisinopril 1 Immunotherapy 1 Dexamethasone 1 Bevacizumab 1 Betaine 1 Adrenal Cortex Hormones 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05530655 2026-01-13

A Study to Determine the Preferred Dose of the Drug, Lisinopril, for Preventing Urinary Toxicity Following Radiotherapy for Prostate Cancer

University of Rochester

Phase EARLY_PHASE1 Recruiting

Prostatic Neoplasms, Radiation Injuries

Data powered by HemOnc (CC BY 4.0) Colophon ⚡